Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Arjo AB ( ($SE:ARJO.B) ) just unveiled an update.
Arjo AB reported a stable first quarter of 2026 with net sales of SEK 2,698 million and organic growth of 3.8%, driven by solid demand for capital goods in the U.S., strong diagnostic and service performance, and contributions from emerging markets including India and a major bed and mattress delivery to public healthcare facilities in South Africa. Despite slightly lower gross margins due to unfavorable product mix, currency effects, U.S. tariffs, and rising transportation and energy costs linked to the Middle East situation, the company improved profit after financial items and cash flow from operations, while CEO Andréas Elgaard emphasized that Arjo is entering a new phase to become more focused and profitable through clearer priorities, efficiency measures, and a sharpened long-term strategic direction.
The most recent analyst rating on ($SE:ARJO.B) stock is a Hold with a SEK32.00 price target. To see the full list of analyst forecasts on Arjo AB stock, see the SE:ARJO.B Stock Forecast page.
More about Arjo AB
Arjo AB is a medical technology company that provides equipment and solutions for patient handling, medical beds, therapeutic mattresses, and related diagnostics and services, primarily to hospitals and long-term care facilities. The company focuses on improving patient safety, comfort, and caregiver working conditions, with a notable presence in the U.S., Europe, and emerging markets such as India and South Africa.
Average Trading Volume: 636,130
Technical Sentiment Signal: Sell
Current Market Cap: SEK7.33B
Learn more about ARJO.B stock on TipRanks’ Stock Analysis page.